TREA

88166343 - HELIXMITH

Follow

Information

  • Trademark
  • 88166343
  • Serial Number
    88166343
  • Registration Number
    5906698
  • Filing Date
    October 23, 2018
    6 years ago
  • Registration Date
    November 12, 2019
    5 years ago
  • Transaction Date
    November 12, 2024
    2 months ago
  • Status Date
    November 12, 2019
    5 years ago
  • Published for Opposition Date
    May 28, 2019
    5 years ago
  • Location Date
    August 25, 2020
    4 years ago
  • Status Code
    700
  • Current Location
    POST REGISTRATION
    Employee Name
    MAI, TINA
  • Attorney Docket Number
    33730-00070
    Attorney Name
    Connie L. Ellerbach
    Law Office Assigned Location Code
    M80
  • Owners
Information
Mark Drawing Code
4
Mark Identification
HELIXMITH
Case File Statements
  • B00001: In the statement, Column 1, line 1-3,"are deleted", and HELIXMITH CO., LTD (Korea, republic of Corporation) 1 Gwanak-ro 5th Fl. Bldg. 203, Seoul, Korea, South 08826 should be inserted
  • GS0051: reagents for use in veterinary genetic testing for medical use; chemical preparations for pharmaceutical purposes, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; chemical preparations for use in DNA analysis for medical use; drugs for medical purposes, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; reagents for use in medical genetic testing for medical use; pharmaceutical drugs, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; medicines for human purposes, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; pharmaceutical preparations for diagnosis; pharmaceutical preparations for the treatment of immune system related diseases and disorders; ethical medicinal preparations, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; therapeutic drugs and agents, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; biological preparations, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; crude medicines, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; biological preparations for medical use in medical and clinical gene therapy and cell therapy; pharmaceutical preparations, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; biological preparations for medical use, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer
  • PM0001: HELIX MITH
  • GS0351: Retail store services featuring reagents for use in veterinary genetic testing; retail store services featuring chemical preparations for pharmaceutical purposes; retail store services featuring chemical preparations for use in DNA analysis for medical use; retail store services featuring drugs for medical purposes; retail store services featuring reagents for use in medical genetic testing; retail store services featuring pharmaceutical preparations for diagnosis; retail store services featuring pharmaceutical preparations for the treatment of immune system related diseases and disorders; retail store services featuring ethical medicinal preparations; retail store services featuring therapeutic drugs and agents, retail store services featuring biological preparations for medical use
  • GS0421: Research and development of vaccines and medicines; providing information relating to scientific analysis of the genetic information via online networks; scientific research in the fields of biomedicine; biological information analysis, namely, genetic testing for medical research purposes; biological information analysis, namely, genetic testing for scientific research purposes; research and testing services in the fields of bacteriology and virology; drug discovery services; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consultancy relating to the pharmaceutical research and development; pharmaceutical research and development; pharmaceutical research services; laboratory research in the field of gene expression; gene analysis for research; consultancy in analysis of biology sequence processing for medical research purposes; consultancy in analysis of genomics for medical research purposes; scientific research in the fields of medicine/health and pharmacology; analysis of human serum for medical research; analysis of human tissues for medical research; blood analysis services
Case File Event Statements
  • 10/26/2018 - 6 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 11/5/2018 - 6 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 1/3/2019 - 6 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/5/2019 - 6 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/5/2019 - 6 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 1/5/2019 - 6 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/5/2019 - 5 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/8/2019 - 5 years ago
    8 - ASSIGNED TO LIE Type: ALIE
  • 3/13/2019 - 5 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/13/2019 - 5 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/22/2019 - 5 years ago
    11 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/22/2019 - 5 years ago
    12 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/22/2019 - 5 years ago
    13 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/29/2019 - 5 years ago
    14 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/29/2019 - 5 years ago
    15 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/30/2019 - 5 years ago
    16 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/3/2019 - 5 years ago
    17 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 4/3/2019 - 5 years ago
    18 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 4/3/2019 - 5 years ago
    19 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 4/3/2019 - 5 years ago
    20 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 4/3/2019 - 5 years ago
    21 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/12/2019 - 5 years ago
    22 - ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Type: ERRR
  • 4/22/2019 - 5 years ago
    23 - ELECTRONIC RECORD REVIEW COMPLETE Type: FIXD
  • 5/8/2019 - 5 years ago
    24 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/28/2019 - 5 years ago
    25 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/28/2019 - 5 years ago
    26 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/11/2019 - 5 years ago
    27 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF
  • 6/19/2019 - 5 years ago
    28 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 10/6/2019 - 5 years ago
    29 - EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Type: ETOP
  • 11/12/2019 - 5 years ago
    30 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 1/21/2020 - 5 years ago
    32 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 12/3/2019 - 5 years ago
    31 - TEAS SECTION 7 REQUEST RECEIVED Type: ES7R
  • 1/21/2020 - 5 years ago
    33 - CORRECTION UNDER SECTION 7 - PROCESSED Type: COC.
  • 2/18/2020 - 4 years ago
    35 - POST REGISTRATION ACTION CORRECTION Type: XXXX
  • 2/18/2020 - 4 years ago
    36 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 2/18/2020 - 4 years ago
    34 - OTQR WITHDRAWAL FROM PUBLICATION Type: WDRL
  • 2/19/2020 - 4 years ago
    37 - POST REGISTRATION ACTION MAILED - SEC. 7 Type: PRAM
  • 8/10/2020 - 4 years ago
    38 - TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Type: EROP
  • 8/25/2020 - 4 years ago
    39 - CORRECTION UNDER SECTION 7 - PROCESSED Type: COC.
  • 11/12/2024 - 2 months ago
    40 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1